Schedule 13D ownership disclosure

Orchestra BioMed Holdings Inc

Common Stock, par value $0.0001 per share · CUSIP: 68572M106

Event date: 2026-02-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LPReported CIK 0001493215

    Shares: 11,942,426.00 · Class: 19.7%

  • RTW Master Fund, Ltd.Reported CIK 0001493219

    Shares: 5,820,930.00 · Class: 10.0%

  • RTW Innovation Master Fund, Ltd.Reported CIK 0001776733

    Shares: 4,931,727.00 · Class: 8.4%

  • Roderick WongReported CIK 0001493280

    Shares: 11,942,426.00 · Class: 19.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493215-26-000063
Form type
SCHEDULE 13D/A
Filer
Orchestra BioMed Holdings, Inc.
CIK
CIK 1814114
Filed
Feb 25, 2026
Reporting period
Feb 23, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub